
News|Videos|June 17, 2025
RX Review: Expanding options and addressing gaps in RSV prevention
Fact checked by: Morgan Ebert, Executive Editor, Victoria Johnson
In this video, part 2 in a 3-part series, panelists discuss clesrovimab's recent approval and gaps in clinician education.
Advertisement
Advertisement
As the field of RSV prevention continues to grow, pediatricians face both new opportunities and new challenges. From emerging immunoprophylaxis strategies to gaps in clinician and parent education, effective RSV management requires staying ahead of a changing landscape. In this second installment of the HCP Live Network RX Review roundtable on RSV, moderator Albert Rizzo, MD, chief medical officer of the American Lung Association, continues the conversation with leading pediatric experts Tina Tan, MD, and Joanne Nazif, MD.
Related to this article

Diana F. Clarke, PharmD, explains how IMPAACT 2023 supported dolutegravir from birth, plus dosing tips and open questions for preterm infants.

An updated AAP policy statement renews the call to ban raw milk sales, citing pathogen risks to children and pregnant people and an emerging H5N1 concern.

At AAP 2026, Rana Hamdy, MD, discussed when to test children for group A strep, antibiotic selection, and strategies to improve prescribing.

Jonathan Miller, MD, discusses earlier HPV vaccination, individualized conversations with hesitant families, and strategies to improve vaccine uptake.

Jonathan Miller, MD, discusses factors behind lagging HPV vaccination rates and how pediatricians can address common parent concerns.

The latest IDSA histoplasmosis update adds a consensus statement on severe disease and outlines when children with pulmonary infection warrant itraconazole therapy.

Children with FASD given choline before age 6 had 9.1% higher nonverbal IQ and 11.3% better working memory vs placebo 5 years after treatment.
Advertisement
Advertisement

